Replies to post #7023 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

The options action show on CNBC this afternoon featured all three analysts saying XBI is poised for a breakout. This, along with the Street dot com article shows biotech is back in favor, so it should be a better year, at least on the macro level.